Neuronoff News
March 16, 2026
Neuronoff Demonstrates Multi-Site IPG Compatibility for Injectrode Platform, Expanding Neuromodulation Beyond Spinal Cord Stimulation
Needle-Delivered Tripolar Electrode Connects to Standard IPG Connectors; Selectively Stimulates Lumbar DRG, Peripheral Nerve, and Sacral Targets from Single Implantable Pulse Generator
October 8, 2025
Neuronoff Closes Oversubscribed $4.5M Round to Prepare Launch of Injectrode Platform for Chronic Pain
The funding supports scaling production to 1,000 units annually and preparing for a limited U.S. launch in 2026 targeting interventional pain physicians, spinal surgeons, podiatrists, and other specialties treating chronic pain.
January 30, 2025
Neuronoff Secures $5 Million in DOD and NIH Funding to Advance Minimally Invasive Neuromodulation Platform
The Department of Defense (DOD) has recommended $1.73 million to fund a clinical randomized controlled trial (RCT) for the treatment of neurogenic bladder following spinal cord injury, while the National Institutes of Health (NIH) has awarded $3.2 million to support preclinical research in overactive bladder treatment.